Skip to main content
Toggle navigation
Search
Home
Back
Favorite
0
Like
Facebook
Tweet
Print
Session VIII: Therapeutic Approaches to Front Line Ovarian Cancer
Debate: Should PARP Inhibators be the Standard of Care in the Frontline? - YES
Friday, September 23, 2022
12:05 PM – 12:15 PM
Debate Speaker(s)
Robert Coleman, MD, FACOG, FACS
US Oncology Research
Spring, Texas